Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell Lymphomas

Sanjal Desai, MD, Christopher Melani, MD, Kieron Dunleavy, MD, Stefania Pittaluga, MD PhD, Mark A. Ahlman, MD, Andrea Nicole Lucas, RN, Seth M. Steinberg, PhD, Elaine S. Jaffe, MD, Mark Roschewski, MD, Wyndham Wilson, MD

Blood (2019) 134 (Supplement_1): 4102.

https://doi.org/10.1182/blood-2019-127481

Published: 2019

Journal Articles

The Risk of Hepatitis B Reactivation Is Controllable in Patients with Concomitant Hepatitis B Virus Infection during Chimeric Antigen Receptor T-Cell Therapy

Wei Liu, Rui Lv, Wenyang Huang, Hong Liu, Shuhui Deng, MD, Shuhua Yi, MD, Lulu Lv, Jianxiang Wang, MD, Lugui Qiu, MD PhD, Dehui Zou, MD

Blood (2019) 134 (Supplement_1): 2913.

https://doi.org/10.1182/blood-2019-126635

Published: 2019

Journal Articles

Evaluation of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Asmaa Atteya, MD, Aiman Ahmad, MD, Dima Daghstani, BSC, Mohamed A Yassin, MBBS, MSc

Blood (2019) 134 (Supplement_1): 1648.

https://doi.org/10.1182/blood-2019-121834

Published: 2019

Journal Articles

Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL

Marco Picardi, Roberta Della Pepa, Claudia Giordano, Irene Zacheo, Novella Pugliese, Chiara Mortaruolo, Fabio Trastulli, Antonio Giordano, Mariano Lucignano, Maria Di Perna, Marta Raimondo, Claudia Salvatore, Fabrizio Pane

Blood (2019) 133 (5): 498–501.

https://doi.org/10.1182/blood-2018-10-878892

Published: 2019

Journal Articles

Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy

Blood (2018) 132 (Supplement 1): 4209.

https://doi.org/10.1182/blood-2018-99-114850

Published: 2018

Journal Articles

Global Expression Changes of Malignant Plasma Cells over Time Reveals the Evolutionary Development of Signatures of Aggressive Clinical Behavior

Blood (2018) 132 (Supplement 1): 4457.

https://doi.org/10.1182/blood-2018-99-119113

Published: 2018

Journal Articles

Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Standard Chemoimmunotherapy

Chieh-Lung Cheng, MD, Erin Huang, Ming-Kai Chuang, MD, Wen-Chien Chou, MD, PhD, Hwei-Fang Tien, MD, PhD

Blood (2018) 132 (Supplement 1): 4235.

https://doi.org/10.1182/blood-2018-99-114982

Published: 2018

Journal Articles

Reactivation of Hepatitis B Virus Infection in Aplastic Anemia Patients Receiving Immunosuppressive Therapy

Hua Yin, Suli Wang, Xingyu Lu, Wenyi Shen, MD, Ruinan Lu, Yu Zhu, MD PhD, Kourong Miao, Ming Hong, MD PhD, Shuai Wang, MD PhD, Jianfu Zhang, Chun Qiao, Yujie Wu, Xuemei Wu, Guangsheng He, Jianyong Li, MD PhD

Blood (2018) 132 (Supplement 1): 5107.

https://doi.org/10.1182/blood-2018-99-118836

Published: 2018

Journal Articles

High Incidence of Hepatitis B Viral Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Jieun Uhm, MD PhD, Sung-Hyun Kim, MD PhD, Sukjoong Oh, MD PhD, Dae Young Zang, MD PhD, Young Rok Do, PhD MD, Won Sik Lee, MD PhD, Myung Hee Chang, MD, Sung-Eun Lee, MD PhD, Dong-Wook Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3010.

https://doi.org/10.1182/blood-2018-99-117543

Published: 2018

Journal Articles

CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV + /AML Patient: A Case Report from the Impaact P1107 Observational Study

Jingmei Hsu, MD, Marshall Glesby, MDPhD, Tsiporah B. Shore, MD, Catherine Small, MD, Usama Gergis, MD M.B.A, Sebastian A. Mayer, MD, Adrienne A. Phillips, MD MPH, Lawrence D. Petz, MD, Renee Browning, RN, M.S.N, CCRP, Meredith Warshaw, Deborah Persaud, MD, Bryson Yvonne, MD, Koen Van Besien, MD PhD

Blood (2018) 132 (Supplement 1): 2184.

https://doi.org/10.1182/blood-2018-99-117734

Published: 2018

Journal Articles

Managing the Risk of Hepatitis B Virus Reactivation in Patients with B-Cell Lymphomas Treated with Obinutuzumab or Rituximab Immunochemotherapy

Shigeru Kusumoto, MD, Luca Arcaini, MD, Xiaonan Hong, Jie Jin, Won Seog Kim, MD, Ph. D., Yok Lam Kwong, Marion Peters, Yasuhito Tanaka, Andrew D. Zelenetz, MD PhD, Hiroshi Kuriki, Günter Fingerle-Rowson, Tina Nielsen, Eisuke Ueda, Hanna Piper-Lepoutre, Gila Sellam, Kensei Tobinai, MD PhD

Blood (2017) 130 (Supplement 1): 2823.

https://doi.org/10.1182/blood.V130.Suppl_1.2823.2823

Published: 2017

Journal Articles

Hepatitis B Virus Seropositivity in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors: Preliminary Results of a Single-Center Cross-Sectional Study

Nurgul Ozgur Yurttas, MD, Burak Sarilar, MD, Ahmet Emre Eskazan, MD, Deniz Ozmen, MD, Dilek Keskin, MD, Sevil Sadri, MD, Selin Berk, MD, Ayse Salihoglu, MD, M. Cem Ar, MD PhD, Seniz Ongoren, MD, Zafer Baslar, MD, Yildiz Aydin, MD, Teoman Soysal, MD

Blood (2017) 130 (Supplement 1): 2888.

https://doi.org/10.1182/blood.V130.Suppl_1.2888.2888

Published: 2017

Journal Articles

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Blood (2017) 130 (Supplement 1): 5213.

https://doi.org/10.1182/blood.V130.Suppl_1.5213.5213

Published: 2017

Journal Articles

Evaluation of a Hepatitis B Virus Reactivation Prevention Program in Lymphoma Patients Receiving Immunochemotherapy

Blanca Sanchez-Gonzalez, MD PhD, Montserrat Garcia-Retortillo, MD PhD, Teresa Murcia, PhD, Mariana Ferraro, MD, Francesc Garcia-Pallarols, BSc, Dolors Gimenez, Sara Montesdeoca, Eva Gimeno, MD PhD, Eugenia Abella, MD PhD, Ricard Sola, MD PhD, Carlos Besses, MD PhD, Antonio Salar, MD PhD

Blood (2016) 128 (22): 1801.

https://doi.org/10.1182/blood.V128.22.1801.1801

Published: 2016

Journal Articles

Evaluation of the Risk of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Ohad Benjamini, MD, Maya Zlotnick, MD, Elena Ribakovsky, MD, Meirav Kedmi, MD, Adrian Duek, MD, Drorit Merkel, MD, Merav Leiba, MD, Ivetta Danylesko, MD, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Avichai Shimoni, MD, Abraham Avigdor, MD, Arnon Nagler, Yulia Volchek, MD

Blood (2016) 128 (22): 5429.

https://doi.org/10.1182/blood.V128.22.5429.5429

Published: 2016

Journal Articles

A Comparison of Lamivudine and Entecavir for the Prophylaxis of Hepatitis B Virus Reactivation in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A Single Institutional Experience

Jin Shang, Jing Sun, MD, Zhiping Fan, Fen Huang, Yu Zhang, MD, Qianli Jiang, MD PhD, Hongsheng Zhou, Qifa Liu, MD

Blood (2015) 126 (23): 2026.

https://doi.org/10.1182/blood.V126.23.2026.2026

Published: 2015

Journal Articles

Hepatitis B (HBV) Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Lenalidomide Containing Regimens: A Single Center Experience

Pinar Ataca, MD, Erden Atilla, MD, Ekin Kircali, MD, Ramazan Idilman, MD, Meral Beksac, MD

Blood (2015) 126 (23): 5377.

https://doi.org/10.1182/blood.V126.23.5377.5377

Published: 2015

Journal Articles

Initial Experience with Thrombopoetin Receptor Agonists (TRA) in 5 Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura (ITP)

Mark Kowalczyk, Paul G. Rubinstein, MD, David M Aboulafia, MD

Blood (2014) 124 (21): 5014.

https://doi.org/10.1182/blood.V124.21.5014.5014

Published: 2014

Journal Articles

Risk Factors of Changes in Hepatitis B Antibody Status after Allogeneic Hematopoietic Stem Cell Transplantation in Chinese Children with Thalassemia Major

Xiaoqin Feng, Lina Long, Chunfu Li, MD

Blood (2014) 124 (21): 5809.

https://doi.org/10.1182/blood.V124.21.5809.5809

Published: 2014

Journal Articles

Post-Autotransplant Hepatitis B Virus (HBV) Reactivation in Lymphoma and Multiple Myeloma Patients with Hepatitis B Surface Antigen-Positive or Resolved HBV Infection

Jieun Jang, MD, Hyunsung Park, MD, Jungyeon Lee, MD, Yundeok Kim, MD, Soo Jeong Kim, MD, June-Won Cheong, MD, PhD, Yoo Hong Min, MD,PhD, Jin Seok Kim

Blood (2014) 124 (21): 1196.

https://doi.org/10.1182/blood.V124.21.1196.1196

Published: 2014

NARROW

Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell Lymphomas

The Risk of Hepatitis B Reactivation Is Controllable in Patients with Concomitant Hepatitis B Virus Infection during Chimeric Antigen Receptor T-Cell Therapy

Evaluation of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL

Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy

Global Expression Changes of Malignant Plasma Cells over Time Reveals the Evolutionary Development of Signatures of Aggressive Clinical Behavior

Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Standard Chemoimmunotherapy

Reactivation of Hepatitis B Virus Infection in Aplastic Anemia Patients Receiving Immunosuppressive Therapy

High Incidence of Hepatitis B Viral Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV + /AML Patient: A Case Report from the Impaact P1107 Observational Study

Managing the Risk of Hepatitis B Virus Reactivation in Patients with B-Cell Lymphomas Treated with Obinutuzumab or Rituximab Immunochemotherapy

Hepatitis B Virus Seropositivity in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors: Preliminary Results of a Single-Center Cross-Sectional Study

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Evaluation of a Hepatitis B Virus Reactivation Prevention Program in Lymphoma Patients Receiving Immunochemotherapy

Evaluation of the Risk of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

A Comparison of Lamivudine and Entecavir for the Prophylaxis of Hepatitis B Virus Reactivation in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A Single Institutional Experience

Hepatitis B (HBV) Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Lenalidomide Containing Regimens: A Single Center Experience

Initial Experience with Thrombopoetin Receptor Agonists (TRA) in 5 Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura (ITP)

Risk Factors of Changes in Hepatitis B Antibody Status after Allogeneic Hematopoietic Stem Cell Transplantation in Chinese Children with Thalassemia Major

Post-Autotransplant Hepatitis B Virus (HBV) Reactivation in Lymphoma and Multiple Myeloma Patients with Hepatitis B Surface Antigen-Positive or Resolved HBV Infection

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only